Evidence map›Paper›PMID 38055833›Full record

ArticleNucleic acids research2024

JMnorm: a novel joint multi-feature normalization method for integrative and comparative epigenomics.

Guanjue Xiang, Yuchun Guo, David Bumcrot, Alla Sigova

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guanjue XiangCAMP4 Therapeutics Corp., One Kendall Square, Building 1400 West, Cambridge, MA 02139, USA.ORCID 0000-0003-1328-7197
Yuchun GuoCAMP4 Therapeutics Corp., One Kendall Square, Building 1400 West, Cambridge, MA 02139, USA.ORCID 0000-0003-2357-1546
David BumcrotCAMP4 Therapeutics Corp., One Kendall Square, Building 1400 West, Cambridge, MA 02139, USA.
Alla SigovaCAMP4 Therapeutics Corp., One Kendall Square, Building 1400 West, Cambridge, MA 02139, USA.ORCID 0009-0001-4518-4582

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combinatorial patterns of epigenetic features reflect transcriptional states and functions of genomic regions. While many epigenetic features have correlated relationships, most existing data normalization approaches analyze each feature independently. Such strategies may distort relationships between functionally correlated epigenetic features and hinder biological interpretation. We present a novel approach named JMnorm that simultaneously normalizes multiple epigenetic features across cell types, species, and experimental conditions by leveraging information from partially correlated epigenetic features. We demonstrate that JMnorm-normalized data can better preserve cross-epigenetic-feature correlations across different cell types and enhance consistency between biological replicates than data normalized by other methods. Additionally, we show that JMnorm-normalized data can consistently improve the performance of various downstream analyses, which include candidate cis-regulatory element clustering, cross-cell-type gene expression prediction, detection of transcription factor binding and changes upon perturbations. These findings suggest that JMnorm effectively minimizes technical noise while preserving true biologically significant relationships between epigenetic datasets. We anticipate that JMnorm will enhance integrative and comparative epigenomics.

Indexed as

Computational BiologyEpigenomicsEpigenesis, GeneticGenomeGenomicsProtein Binding

Identifiers

PMID38055833
PMCPMC10810286

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.